Chemical structure of molecule eliapixant (BAY1817080)

oral P2X3 ion channel antagonist

Ph. II, multiple settings (50-750 mg BID)

from literature P2X3 antagonists

Scientific Reports

Bayer AG, Berlin, DE

The Bayer P2X3 purinoreceptor antagonist, eliapixant (BAY1817080), is intended to treat various disorders associated with hypersensitive nerve fibers, including endometriosis. The hypothesis is that P2X3 receptor antagonism can inhibit cycles of…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.